UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$767M |
| 2 |
Amazon
AMZN
|
+$288M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$287M |
| 4 |
NVIDIA
NVDA
|
+$259M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$347M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$316M |
| 3 |
Citigroup
C
|
+$269M |
| 4 |
Charter Communications
CHTR
|
+$229M |
| 5 |
NetEase
NTES
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.35% |
| 2 | Consumer Discretionary | 13.14% |
| 3 | Financials | 12.19% |
| 4 | Healthcare | 12.04% |
| 5 | Communication Services | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTOR
1601
DELISTED
MERITOR, Inc.
MTOR
| $2.51M | ﹤0.01% |
85,403
+1,465
| +2% | +$43.5K |
|
1602
Evertec
EVTC
$1.78B
| $2.51M | ﹤0.01% |
67,345
-371
| -0.5% | -$14K |
|
1603
Cohu
COHU
$2.5B
| $2.51M | ﹤0.01% |
59,879
-2,859
| -5% | -$126K |
|
1604
ESCO Technologies
ESE
$7.92B
| $2.5M | ﹤0.01% |
22,960
+1,274
| +6% | +$135K |
|
1605
J&J Snack Foods
JJSF
$1.71B
| $2.5M | ﹤0.01% |
15,891
-482
| -3% | -$75.6K |
|
1606
MillerKnoll
MLKN
$1.67B
| $2.49M | ﹤0.01% |
60,407
-2,116
| -3% | -$81K |
|
|
ARI
1607
Apollo Commercial Real Estate
ARI
$885M
| $2.48M | ﹤0.01% |
177,492
| – | – |
|
|
MFA
1608
MFA Financial
MFA
$933M
| $2.48M | ﹤0.01% |
152,181
+6,807
| +5% | +$108K |
|
1609
Werner Enterprises
WERN
$2.25B
| $2.48M | ﹤0.01% |
52,491
-302,341
| -85% | -$13.1M |
|
1610
Rambus
RMBS
$11B
| $2.47M | ﹤0.01% |
127,303
-3,018
| -2% | -$60.6K |
|
1611
Onto Innovation
ONTO
$15.3B
| $2.47M | ﹤0.01% |
37,583
| – | – |
|
|
SC
1612
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $2.46M | ﹤0.01% |
91,067
-2,123
| -2% | -$53.2K |
|
|
CVSA
1613
Covista Inc
CVSA
$4.8B
| $2.46M | ﹤0.01% |
62,284
+694
| +1% | +$27.1K |
|
1614
Myriad Genetics
MYGN
$312M
| $2.46M | ﹤0.01% |
80,808
+3,858
| +5% | +$109K |
|
1615
Jack in the Box
JACK
$335M
| $2.45M | ﹤0.01% |
22,358
-239
| -1% | -$24.3K |
|
1616
Edgewell Personal Care
EPC
$1.31B
| $2.44M | ﹤0.01% |
61,726
+61
| +0.1% | +$2.11K |
|
1617
Green Dot
GDOT
$745M
| $2.44M | ﹤0.01% |
53,334
-1,833
| -3% | -$95.5K |
|
|
ALTR
1618
DELISTED
Altair Engineering Inc
ALTR
| $2.43M | ﹤0.01% |
38,842
+4,997
| +15% | +$305K |
|
1619
BridgeBio Pharma
BBIO
$16.5B
| $2.43M | ﹤0.01% |
39,441
-125,961
| -76% | -$8.24M |
|
1620
Live Oak Bancshares
LOB
$1.97B
| $2.42M | ﹤0.01% |
35,357
-933
| -3% | -$49K |
|
|
APLS
1621
DELISTED
Apellis Pharmaceuticals
APLS
| $2.41M | ﹤0.01% |
56,259
-8,688
| -13% | -$411K |
|
1622
Shenandoah Telecom
SHEN
$746M
| $2.41M | ﹤0.01% |
49,371
| – | – |
|
1623
Editas Medicine
EDIT
$442M
| $2.41M | ﹤0.01% |
57,288
-11,494
| -17% | -$655K |
|
|
MGLN
1624
DELISTED
Magellan Health Services, Inc.
MGLN
| $2.41M | ﹤0.01% |
25,800
+3,219
| +14% | +$302K |
|
1625
BioCryst Pharmaceuticals
BCRX
$2.4B
| $2.37M | ﹤0.01% |
233,413
-19,212
| -8% | -$198K |
|
Similar funds
UBS AM's Q1 2021 Portfolio in Review
As of Q1 2021, UBS AM held 2,645 positions worth $226B, up 6% from $213B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 4.9%. UBS AM opened 86 new positions and exited 44, leaving the 2,645-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Financials.
- UBS AM's largest Q1 2021 buy was Seagen Inc. Common Stock: 966,114 shares worth $134M.
- UBS AM added most to Infosys in Q1 2021, an estimated $767M increase.
- UBS AM's biggest Q1 2021 reduction was Alibaba, cutting an estimated $347M.
- UBS AM fully exited Lumen in Q1 2021, selling an estimated $45.5M.
- UBS AM's ten largest holdings make up 22% of its $226B portfolio in Q1 2021.
- UBS AM opened 86 new positions and closed 44 in Q1 2021.
- UBS AM's portfolio value rose 6% quarter-over-quarter to $226B.
Based on UBS AM's 13F filing for Q1 2021, filed 14 May 2021.